R Bucovec
- Co-authors
- Paolo LissoniFabio MaluganiFranco RovelliArio ContiGeorges J. M. MaestroniG GardaniMassimo VaghiGabriele Tancini
- Topics
- Immunotherapy and Immune Responses (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)Circadian rhythm and melatonin (3 papers)
- Partner nations
- Italy
In The Last Decade
R Bucovec
11 papers receiving 416 citations
Peers
Comparison fields: 5 of 72
- Endocrine and Autonomic Systems 170
- Molecular Biology 140
- Oncology 129
- Immunology 105
- Physiology 67
Countries citing papers authored by R Bucovec
This map shows the geographic impact of R Bucovec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Bucovec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Bucovec more than expected).
Fields of papers citing papers by R Bucovec
This network shows the impact of papers produced by R Bucovec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Bucovec. The network helps show where R Bucovec may publish in the future.
Co-authorship network of co-authors of R Bucovec
This figure shows the co-authorship network connecting the top 25 collaborators of R Bucovec. A scholar is included among the top collaborators of R Bucovec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Bucovec. R Bucovec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. | 87 |
| 2 | Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patients. | 6 |
| 3 | Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. | 88 |
| 4 | Ten-year survival results in metastatic renal cell cancer patients treated with monoimmunotherapy with subcutaneous low-dose interleukin-2. | 19 |
| 5 | Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients. | 3 |
| 6 | A clinical study of taxotere versus taxotere plus the antiprolactinemic agent bromocriptine in metastatic breast cancer pretreated with anthracyclines. | 19 |
| 7 | 20 | |
| 8 | Serum concentrations of interleukin-18 in early and advanced cancer patients: enhanced secretion in metastatic disease. | 33 |
| 9 | Anti-angiogenic activity of melatonin in advanced cancer patients. | 138 |
| 10 | 15 | |
| 11 | 12 |
About R Bucovec
R Bucovec is a scholar working on Endocrine and Autonomic Systems, Immunology and Oncology, having authored 11 papers that have together received 440 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Circadian rhythm and melatonin (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (170 citations), Biological Psychiatry (18 citations) and Immunology (105 citations). R Bucovec has collaborated with scholars based in Italy. Frequent co-authors include Paolo Lissoni, Fabio Malugani, Franco Rovelli, Ario Conti, Georges J. M. Maestroni, G Gardani, Massimo Vaghi, Gabriele Tancini, A Ardizzoia and F Brivio. Their work appears in journals such as Journal of Pineal Research, The International Journal of Biological Markers and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.